Study of acute myeloid leukemia patients shows protein inhibitor drug safe and effective with durable remissions
Ivosidenib, an experimental drug that inhibits a protein often mutated in several cancers has been shown to be safe, resulting in durable remissions, in a study of acute myeloid leukemia (AML) with relapsed or refractory ...
Jun 3, 2018
0
5